Market Cap 12.59B
Revenue (ttm) 4.24B
Net Income (ttm) 32.61M
EPS (ttm) N/A
PE Ratio 97.12
Forward PE 13.90
Profit Margin 0.77%
Debt to Equity Ratio 0.00
Volume 3,737,600
Avg Vol 2,038,332
Day's Range N/A - N/A
Shares Out 193.57M
Stochastic %K 65%
Beta 0.68
Analysts Sell
Price Target $74.05

Latest News on INCY

Incyte to Present at Upcoming Investor Conference

May 27, 2025, 8:00 AM EDT - 6 days ago

Incyte to Present at Upcoming Investor Conference


Incyte Corporation (INCY) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 12:53 PM EDT - 4 weeks ago

Incyte Corporation (INCY) Q1 2025 Earnings Call Transcript


Incyte to Report First Quarter Financial Results

Apr 10, 2025, 8:00 AM EDT - 7 weeks ago

Incyte to Report First Quarter Financial Results


Incyte Is Today's Worst S&P 500 Stock. Here's Why.

Mar 17, 2025, 11:21 AM EDT - 2 months ago

Incyte Is Today's Worst S&P 500 Stock. Here's Why.


Incyte to Present at Upcoming Investor Conferences

Feb 18, 2025, 8:00 AM EST - 3 months ago

Incyte to Present at Upcoming Investor Conferences


Incyte: Q4 Earnings Outlines Multiple Drug Launches In 2025

Feb 11, 2025, 7:30 AM EST - 3 months ago

Incyte: Q4 Earnings Outlines Multiple Drug Launches In 2025


Incyte Corporation (INCY) Q4 2024 Earnings Call Transcript

Feb 10, 2025, 11:52 AM EST - 3 months ago

Incyte Corporation (INCY) Q4 2024 Earnings Call Transcript


Incyte: Multiple Drug Launches Bode Well For Future Growth

Jan 11, 2025, 9:30 AM EST - 5 months ago

Incyte: Multiple Drug Launches Bode Well For Future Growth